Evidence for a Founder Effect ofSDHBExon 1 Deletion in Brazilian Patients With Paraganglioma

MLA

Gustavo F C Fagundes, et al. “Evidence for a Founder Effect OfSDHBExon 1 Deletion in Brazilian Patients With Paraganglioma.” The Journal of Clinical Endocrinology & Metabolism, Jan. 2023. EBSCOhost, https://doi.org/10.1210/clinem/dgad028.

APA

Gustavo F C Fagundes, Felipe Freitas-Castro, Lucas S Santana, Ana Caroline F Afonso, Janaina Petenuci, Mariana F A Funari, Augusto G Guimaraes, Felipe L Ledesma, Maria Adelaide A Pereira, Carolina R Victor, Marcela S M Ferrari, Fernando M A Coelho, Victor Srougi, Fabio Y Tanno, Jose L Chambo, Ana Claudia Latronico, Berenice B Mendonca, Maria Candida B V Fragoso, Ana O Hoff, & Madson Q Almeida. (2023). Evidence for a Founder Effect ofSDHBExon 1 Deletion in Brazilian Patients With Paraganglioma. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad028

Chicago

Gustavo F C Fagundes, Felipe Freitas-Castro, Lucas S Santana, Ana Caroline F Afonso, Janaina Petenuci, Mariana F A Funari, Augusto G Guimaraes, et al. 2023. “Evidence for a Founder Effect OfSDHBExon 1 Deletion in Brazilian Patients With Paraganglioma.” The Journal of Clinical Endocrinology & Metabolism, January. doi:10.1210/clinem/dgad028.